Top Tech Companies (719)
Don't see your company?
Create a company profile
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
Genesee Scientific, a life science products company, is a leading supplier of products to global life science research markets. With thousands of products available, its markets include pharmaceutical and biotechnology companies, medical research institutions, research and development laboratories, universities, colleges and secondary education institutions, hospitals, reference labs, and quality control/process control laboratories.
Ceregene is a biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
.jpg)
Your Partners in Medical Affairs - The Medical Affairs Company (TMAC) provides a full range of flexible and customizable medical affairs solutions to meet our Clients' needs. TMAC’s services include the provision of contract field-based medical teams, medical information, and medical affairs consulting, all designed to address company resource, timing and budget challenges. Field-based Medical Affairs Careers: We’ve set the industry standard in contract field-based medical affairs recruiting. TMAC’s internal specialized Talent Acquisition Team has a 20-year track record of success in building national field-based Medical Affairs and MSL Teams. They are adept at identifying and attracting the right individuals to fit the needs of each specific program and matching a candidate's talent to the skill set required for each position. Work alongside our clients, including many of the top ten pharma companies around the globe, as well as up and coming companies who are advancing cutting edge science and novel technology. Mesh your own science and business acumen as we improve the way medicine impacts lives. Whether you’re actively seeking a position or just keeping an open door to opportunities, we deliver the right people to the right companies, every time. TMAC’s Executive Leaders and management team have been actively involved in the outsourced medical affairs sector for over 20 years and have continued to further develop and evolve strategic solutions that meet the needs of today’s biopharmaceutical, diagnostic and medical device clients. TMAC realizes that not all programs are alike and customizes each program to the specific company’s culture, therapeutic area, product lifecycle stage and stakeholders needs. The Management Team of department leads, field medical Directors & Managers is made up of some of the best talent in the industry with unmatched experience working with programs of all sizes and specialties and in a wide range of therapeutic areas.
GeneBiology develops a patented new drugs for serious diseases using the 505(b)(2) regulatory pathway.
Sekisui XenoTech is a pharmaceutical company offering pharmaceutical safety testing and drug metabolism services.
Lipocine is a specialty pharmaceutical company that develops and commercializes pharmaceutical products.
Mixlab is the first modern, tech-enabled pet pharmacy that focuses on creating custom medications and delightful experiences for pets, their parents and veterinarians. By putting service at the heart of everything we do, our talented team is able to provide the best personalized care for our patients, as well as those who care for them.
Polaris Pharmacy Services is the leading provider of long-term care pharmacy solutions serving multiple locations across the eastern United States. We at Polaris are committed to exceptional service and excellent value and we count on different programs that can help meet your needs. Our technology based solutions include, enhanced clinical services, client web portal, web-based discharge program, HIPAA compliant communication, ePrescribing, and a myriad of education options to help your facility stay compliant. Our caring approach has been built on years of long-term care experience and we know that through service and dedication to our clients we can provide the quality and care that you deserve.
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.
.jpeg)
.png)
Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
Over 10 years ago, Peachtree was founded to fill a perceived missing principle in typical CRO services. Where can I find a CRO that will partner with me, understand my challenges, and solve issues to keep my program on track? Filling this need requires experienced clinical research professionals. We focused on people – building an organization by investing in highly experienced personnel with broad therapeutic area expertise in a number of clinical trials. From single-center Phase I to global multi-center trials. Most all of our clinical personnel have both sponsor and CRO experience – allowing us to fully understand the issues our sponsor-clients face. We built a rock-solid processes and systems infrastructure to support the teams and this investment continues today – always seeking to improve our service. We also saw the opportunity to support an under-served segment of the market – emerging mid-sized companies. We felt they could benefit from access to highly-experienced teams that understand the challenges of limited resources and be flexible, reliable, and responsive. Most of all – provide solutions. So where is Peachtree today? A full-service CRO offering project management, feasibility & subject recruitment, clinical site management & monitoring, data management, biostatistics, medical monitoring, medical writing, and clinical quality assurance We are 80+ highly-experienced clinical research professionals with an average of more than 20 years relevant clinical experience Our client roster continues to grow having worked with nearly 100 pharmaceutical, biotech, and medical device companies providing full-service clinical trial support to niche services Continued investment in best-in-class systems such as IBM Clinical for EDC, Veeva Vault for eTMF, ZenQMS for quality management and training, and Oracle for CTMS
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
In 1921, Guy Hollister, a chemist, and Dr. Robert Stier, a pathologist, developed a treatment to bring relief to the allergy suffering in their own families. From those beginnings a company dedicated to putting an end to allergy suffering was born, HollisterStier Allergy. Over the years that focus has not wavered, and our quest for better ways to do things continues. We take pride in the quality of our extracts, and our research and development group continually looks at ways to improve them. Our constant search for better ways to do things and an overwhelming need to help allergy sufferers get more out of life have led us to some unique products like our multiple skin test devices, and our phenol free antigens. And we are working on all kinds of other great new ideas.
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
RxSolutions is a company that specializes in customized pharmaceutical reimbursement programs.
CinRx Pharma is a mosaic of biotechnology companies supported by a dedicated funding mechanism designed to improve drug development success by accelerating promising new medicines to patients. Integrating our pre-clinical, clinical and operational expertise with multiple shots on goal, we customize the optimal development trajectory for each pipeline candidate – a drug development superhighway. Our deliberate approach to asset selection is driven by deep operational and scientific expertise combined with decades of experience treating patients and developing new drugs. We invest in candidate drugs that have the potential for transformational change in the way a disease area is treated and significantly improves the patient experience and quality of life.
IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve operations. Headquartered in Pennsylvania, IPS is a multinational company with over 1,800 professionals and 23 offices in 10 countries in the United States, Canada, Brazil, the United Kingdom, Ireland, Germany, Switzerland, Singapore, China, and India. With the newest acquisition of Linesight, IPS has over 3,000 professionals in 45+ offices across 17 countries in the Americas, Europe, Asia Pacific, Southeast Asia, Australia, and the Middle East. Linesight specializes in cost, schedule, risk, program, and project management services in various market sectors, including data centers, life sciences, and high-tech industrial.
Tandem Labs is a leading bioanalytical Contract Research Organization (CRO) specializing in advanced mass spectrometry.
